Jonathan Poole
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jonathan Poole
Jonathan Poole is recorded as CFO at Vertex Pharmaceuticals Inc / Ma (VRTX). Vertex Pharmaceuticals Inc / Ma reported in an 8-K filed September 1, 2026 that Jonathan Poole was appointed Executive Vice President and Chief Financial Officer, effective January 1, 2027.
“On August 27, 2026, Vertex Pharmaceuticals Incorporated (the “Company”) appointed Jonathan Poole as Executive Vice President and Chief Financial Officer of the Company, effective January 1, 2027 (the “Effective Date”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2027-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Vertex Pharmaceuticals Inc / Ma
Other people whose current roles at this company are on record from its filings.
- Dr. Reshma Kewalramani CEO
- Reshma Kewalramani CEO, Board Member
- Dr. Jeffrey M. Leiden Chairman
- Jeffrey Leiden Chairman, Board Member
- Charles Wagner CFO
- Charles F. Wagner, Jr. COO
- Stuart Arbuckle COO
- Alan Garber Board Member
- Bruce Sachs Board Member
- Diana McKenzie Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.